Literature DB >> 27549434

Investigation of suitable starting doses of narrowband UVB in Asian vitiligo patients: a pilot study.

H Lee1, H Chu1, S H Oh1.   

Abstract

BACKGROUND: Phototherapy is the preferred treatment modality for active and generalized vitiligo. One of the widely accepted consensus on starting dose of phototherapy is using a uniform dose of 280 mJ/cm2 regardless of patients' Fitzpatrick skin phototype (SPT). However, in many clinical experiences with Asian vitiligo patients, the protocol seems suboptimal.
OBJECTIVE: To gather more evidence on establishing a higher starting dosage for Asian vitiligo patients undergoing phototherapy.
METHODS: We enrolled generalized vitiligo patients with lesions sized adequate enough for phototest. Minimal erythema dose (MED) of vitiligo lesion and non-lesion was measured along with melanin index (MI).
RESULTS: Relatively, a wide range of MED and MI was observed even among patients with similar SPT. The range of MED for lesional skin was 300-700 mJ/cm2 and the MED for non-lesion was 500-800 mJ/cm2 . Correlation was noted between lesional MED and non-lesional MI (Spearman correlation, ρ = 0.664 [P < 0.036]) and mean lesional MED was approximately 65% of mean non-lesional MED.
CONCLUSION: Results from phototest and tolerability of patients to doses higher than 280 mJ/cm2 may indicate that higher starting doses might be appropriate for Asian vitiligo patients.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2016        PMID: 27549434     DOI: 10.1111/jdv.13933

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

1.  Adipose-derived stem cells attenuate acne-related inflammation via suppression of NLRP3 inflammasome.

Authors:  Xiaoxi Li; Sai Luo; Xinyao Chen; Shasha Li; Lijun Hao; Dan Yang
Journal:  Stem Cell Res Ther       Date:  2022-07-23       Impact factor: 8.079

2.  Identification of factors associated with minimal erythema dose variations in a large-scale population study of 22 146 subjects.

Authors:  Y Tan; F Wang; G Fan; Y Zheng; B Li; N Li; Y Liu; X Wang; W Liu; J Krutmann; Y Zou; S Wang
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-02-27       Impact factor: 6.166

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.